Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up:Results of a randomized controlled trial (SCHEDULE)

MLA

A.R. Authen, et al. Effect of Everolimus vs Calcineurin Inhibitors on Quality of Life in Heart Transplant Recipients during a 3-Year Follow-up:Results of a Randomized Controlled Trial (SCHEDULE). Sept. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9453ee64337354be12104c099800b8ef&authtype=sso&custid=ns315887.

APA

A.R. Authen, D. Solbu, Finn Gustafsson, Einar Gude, Hans Eiskjær, Arne K. Andreassen, Kristjan Karason, Satish Arora, I. Grov, Göran Rådegran, Lars Gullestad, Göran Dellgren, & Kjell Jansson. (2017). Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up:Results of a randomized controlled trial (SCHEDULE).

Chicago

A.R. Authen, D. Solbu, Finn Gustafsson, Einar Gude, Hans Eiskjær, Arne K. Andreassen, Kristjan Karason, et al. 2017. “Effect of Everolimus vs Calcineurin Inhibitors on Quality of Life in Heart Transplant Recipients during a 3-Year Follow-up:Results of a Randomized Controlled Trial (SCHEDULE),” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9453ee64337354be12104c099800b8ef&authtype=sso&custid=ns315887.